Where PDA works primarily through VEGFR2 and nitric oxide pathways, GHK-Cu works through copper-dependent enzyme activation and gene regulation
Care moves from qualification to prescription with minimal friction, while physician oversight remains central
While injectable GLP-1 therapies have proven effective, injection-based treatments present barriers for some patients
Most protocols recommend follow-up every 48 weeks during dose titration and every 36 months once on a stable maintenance dose
Strilchuk, L., Fogacci, F
The Precision Peptide Genetic Test examines variants such as GIPR rs1800437, FTO rs9939609 , and MC4R rs17782313, which describe baseline biology across those pathways results meant to be interpreted with a qualified provider alongside clinical biomarkers